Physician

Henry J Shapiro, MD

According to 2025 Medicare claims, Henry Shapiro, MD (NPI: 1477591709) practices hematology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is GENESISCARE USA OF FLORIDA LLC (NPI: 1649648080; TIN: 59-2485899) and primary practice location at 33458-7395.

Shapiro's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 356 traditional Medicare patients, billed 141,785 HCPCS/CPT codes, and received $1,573,236 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 854 prescription claims across 143 beneficiaries totaling $2,302,854 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 36 claims. Open Payments data shows 105 records totaling $2,163. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $390,703 to $2,302,854. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	329	131,258	$1,309,026
2016	337	141,449	$1,148,475
2017	311	108,107	$1,464,994
2018	312	134,491	$1,847,908
2019	328	124,089	$1,736,019
2020	319	156,887	$1,676,328
2021	320	143,174	$1,453,847
2022	302	178,271	$1,387,130
2023	332	179,504	$1,743,361
2024	356	141,785	$1,573,236

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	131	1,080	$390,703
2016	134	962	$410,615
2017	112	847	$212,150
2018	138	985	$408,161
2019	141	1,065	$883,120
2020	173	1,329	$1,738,874
2021	159	1,517	$2,227,503
2022	162	1,231	$2,081,956
2023	162	1,235	$2,135,374
2024	143	854	$2,302,854

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	114	$29,848
2016	N/R	43	$2,266
2017	N/R	37	$10,202
2018	N/R	56	$7,171
2019	N/R	18	$4,009
2020	N/R	36	$3,194
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	33	$44,780
2024	N/R	36	$50,273

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	246	640	$110
80053	Blood test, comprehensive group of blood chemicals	219	514	$10
36415	Insertion of needle into vein for collection of blood sample	289	1,215	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	263	1,068	$8
83615	Lactate dehydrogenase (enzyme) level	169	218	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	36	1,080	$550,330
Pomalyst	Pomalidomide	21	588	$452,016
Jakafi	Ruxolitinib Phosphate	20	600	$361,227
Lenalidomide	Lenalidomide	18	497	$245,659
Brukinsa	Zanubrutinib	14	420	$212,524

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	12	$49,268
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	12	$882
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	12	$123

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	105	$2,163	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Henry J. Shapiro, MD?

Tedicare shows public-source Medicare data for Henry J. Shapiro, MD (NPI 1477591709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Henry J. Shapiro, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Henry J. Shapiro, MD?

Henry J. Shapiro, MD is linked to GENESISCARE USA OF FLORIDA LLC (billing NPI 1649648080) in the available physician profile data.

Does Henry J. Shapiro, MD have Open Payments data?

Henry J. Shapiro, MD has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.